05:28 PM EST, 12/03/2025 (MT Newswires) -- Howard G. Welgus, Director, on December 01, 2025, sold 10,000 shares in Arcutis Biotherapeutics ( ARQT ) for $302,133. Following the Form 4 filing with the SEC, Welgus has control over a total of 79,744 common shares of the company, with 79,744 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1787306/000180105025000008/xslF345X05/wk-form4_1764800618.xml